Frontiers in Oncology | Thoracic Oncology

Case Report

Published on 23 Sep 2022

A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review

in Thoracic Oncology

Xiaohu Xu
Dong Chen
Xiao Wu
Qi Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.988625

3,499 views
8 citations

Mini Review

Published on 21 Sep 2022

Minimal residual disease in EGFR-mutant non-small-cell lung cancer

in Thoracic Oncology

Nathan T. Bain
Yang Wang
Surein Arulananda

Frontiers in Oncology

doi 10.3389/fonc.2022.1002714

5,056 views
4 citations

Original Research

Published on 20 Sep 2022

Development and validation of a screening model for lung cancer using machine learning: A large-scale, multi-center study of biomarkers in breath

in Thoracic Oncology

Jing Li
Yuwei Zhang
Qing Chen
Zhenhua Pan
Jun Chen
Meixiu Sun
Junfeng Wang
Yingxin Li
Qing Ye

Frontiers in Oncology

doi 10.3389/fonc.2022.975563

3,923 views
9 citations

Original Research

Published on 20 Sep 2022

The efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A Chinese multicenter real-world study

in Thoracic Oncology

Hao-Ran Zheng
Ai-Min Jiang
Huan Gao
Na Liu
Xiao-Qiang Zheng
Xiao Fu
Zhi-Ping Ruan
Tao Tian
Xuan Liang
Yu Yao

Frontiers in Oncology

doi 10.3389/fonc.2022.894835

3,813 views
8 citations

Case Report

Published on 20 Sep 2022

Malignant granular cell tumor in the thoracic wall: A case report

in Thoracic Oncology

Shengnan Gao
Bin Xing
Sun Lichao
Jie Luo
Jiao Tang
Ye Wang
Xiaoyan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.895924

4,496 views
2 citations

Systematic Review

Published on 20 Sep 2022

Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: A Bayesian network meta-analysis of randomized controlled trials

in Thoracic Oncology

Yi-Fang Xu
Yun-Ru Chen
Fan-Long Bu
Yu-Bei Huang
Yu-Xin Sun
Cheng-Yin Li
Jodi Sellick
Jian-Ping Liu
Dan-Mei Qin
Zhao-Lan Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.942941

6,095 views
6 citations

Original Research

Published on 20 Sep 2022

Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasms

in Thoracic Oncology

Man Liu
Wanming Hu
Yixuan Zhang
Ning Zhang
Luohai Chen
Yuan Lin
Yu Wang
Yanji Luo
Yu Guo
Minhu Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.917743

3,203 views
6 citations

Original Research

Published on 20 Sep 2022

Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer

in Thoracic Oncology

Waleed Kian
Petros Christopoulos
Areen A. Remilah
Esther Levison
Elizabeth Dudnik
Walid Shalata
Bilal Krayim
Ranin Marei
Alexander Yakobson
Martin Faehling

Frontiers in Oncology

doi 10.3389/fonc.2022.1010311

8,070 views
14 citations

Original Research

Published on 16 Sep 2022

Propensity score-matched comparison of robotic- and video-assisted thoracoscopic surgery, and open lobectomy for non-small cell lung cancer patients aged 75 years or older

in Thoracic Oncology

Hanbo Pan
Zenan Gu
Yu Tian
Long Jiang
Hongda Zhu
Junwei Ning
Jia Huang
Qingquan Luo

Frontiers in Oncology

doi 10.3389/fonc.2022.1009298

4,565 views
26 citations

Original Research

Published on 16 Sep 2022

The value of narrow-band imaging bronchoscopy in diagnosing central lung cancer

in Thoracic Oncology

Juanjuan Zhu
Rui Liu
Xiancheng Wu
Qin Li
Beilei Gong
Yuanbing Shen
Yurong Ou
Wei Li

Frontiers in Oncology

doi 10.3389/fonc.2022.998770

5,035 views
7 citations

Editorial

Published on 16 Sep 2022

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways

in Thoracic Oncology

Giannis Mountzios
Giuseppe Luigi Banna
Christian Rolfo

Frontiers in Oncology

doi 10.3389/fonc.2022.997404

2,778 views
2 citations

Original Research

Published on 15 Sep 2022

Expression and clinical significance of CD31, CD34, and CD105 in pulmonary ground glass nodules with different vascular manifestations on CT

in Thoracic Oncology

Chen-ran Guo
Rui Han
Feng Xue
Lin Xu
Wan-gang Ren
Meng Li
Zhen Feng
Ben-chuang Hu
Zhong-min Peng

Frontiers in Oncology

doi 10.3389/fonc.2022.956451

8,002 views
19 citations

Original Research

Published on 15 Sep 2022

Establishment and validation of a radiological-radiomics model for predicting high-grade patterns of lung adenocarcinoma less than or equal to 3 cm

in Thoracic Oncology

Hao Dong
Lekang Yin
Lei Chen
Qingle Wang
Xianpan Pan
Yang Li
Xiaodan Ye
Mengsu Zeng

Frontiers in Oncology

doi 10.3389/fonc.2022.964322

2,699 views
12 citations

Original Research

Published on 15 Sep 2022

Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer

in Thoracic Oncology

Rebekah Rittberg
Bonnie Leung
Zamzam Al-Hashami
Cheryl Ho

Frontiers in Oncology

doi 10.3389/fonc.2022.1002385

5,497 views
12 citations

Original Research

Published on 15 Sep 2022

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma

in Thoracic Oncology

Jianlong Tan
Fengyu Chen
Bin Ouyang
Xiuying Li
Weidong Zhang
Xinglin Gao

Frontiers in Oncology

doi 10.3389/fonc.2022.865756

3,841 views
10 citations

Original Research

Published on 14 Sep 2022

PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach

in Thoracic Oncology

Antonella Fameli
Valerio Nardone
Mojtaba Shekarkar Azgomi
Giovanna Bianco
Claudia Gandolfo
Bianca Maria Oliva
Marika Monoriti
Rita Emilena Saladino
Antonella Falzea
Caterina Romeo

Frontiers in Oncology

doi 10.3389/fonc.2022.911579

5,539 views
8 citations

Original Research

Published on 14 Sep 2022

Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity

in Thoracic Oncology

Rirong Qu
Dehao Tu
Yixin Cai
Wei Ping
Xiangning Fu

Frontiers in Oncology

doi 10.3389/fonc.2022.979522

2,871 views
5 citations

Original Research

Published on 14 Sep 2022

Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors

in Thoracic Oncology

Richard Benjamin Young
Hemali Panchal
Weijie Ma
Shuai Chen
Aaron Steele
Andrea Iannucci
Tianhong Li

Frontiers in Oncology

doi 10.3389/fonc.2022.980181

2,585 views
6 citations

Original Research

Published on 14 Sep 2022

Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review

in Thoracic Oncology

Guohua Jia
Shuimei Zhou
Tangpeng Xu
Yabing Huang
Xiangpan Li

Frontiers in Oncology

doi 10.3389/fonc.2022.954685

3,205 views
4 citations

Original Research

Published on 14 Sep 2022

Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung

in Thoracic Oncology

Hongbiao Wang
Jun Liu
Sujuan Zhu
Kun Miao
Zhifeng Li
Xiaofang Qi
Lujia Huang
Lijie Guo
Yan Wang
Yuyin Cai

Frontiers in Oncology

doi 10.3389/fonc.2022.945843

6,472 views
12 citations

Original Research

Published on 14 Sep 2022

The combined role of PET/CT metabolic parameters and inflammatory markers in detecting extensive disease in small cell lung cancer

in Thoracic Oncology

Yao Hu
Jin Sun
Danming Li
Yangyang Li
Tiannv Li
Yuxiao Hu

Frontiers in Oncology

doi 10.3389/fonc.2022.960536

2,794 views
3 citations

Case Report

Published on 14 Sep 2022

Drug-induced liver injury associated with dacomitinib: A case report

in Thoracic Oncology

Xuanxuan Wang
Anqi Huang
Yun Lu
Suyu Gao
Wen Hu
Hong Cheng

Frontiers in Oncology

doi 10.3389/fonc.2022.979462

3,056 views
8 citations

Brief Research Report

Published on 13 Sep 2022

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases

in Thoracic Oncology

Xin Li
Chunqiu Xia
Minghui Liu
Jinghao Liu
Ming Dong
Honglin Zhao
Song Xu
Dan Wang
Sen Wei
Zuoqing Song

Frontiers in Oncology

doi 10.3389/fonc.2022.843116

3,142 views
1 citation

Original Research

Published on 13 Sep 2022

A detection panel of novel methylated DNA markers for malignant pleural effusion

in Thoracic Oncology

Chaonan Liang
Nan Liu
Qin Zhang
Mingming Deng
Jiangwei Ma
Jingwen Lu
Yan Yin
Jian Wang
Yuan Miao
Bin She

Frontiers in Oncology

doi 10.3389/fonc.2022.967079

4,472 views
21 citations

1,964 articles

articles

A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review

Minimal residual disease in EGFR-mutant non-small-cell lung cancer

Development and validation of a screening model for lung cancer using machine learning: A large-scale, multi-center study of biomarkers in breath

The efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A Chinese multicenter real-world study

Malignant granular cell tumor in the thoracic wall: A case report

Chinese herbal injections versus intrapleural cisplatin for lung cancer patients with malignant pleural effusion: A Bayesian network meta-analysis of randomized controlled trials

Clinical implications of immune checkpoint markers and immune infiltrates in patients with thymic neuroendocrine neoplasms

Real-world efficacy and safety of mobocertinib in EGFR exon 20 insertion-mutated lung cancer

Propensity score-matched comparison of robotic- and video-assisted thoracoscopic surgery, and open lobectomy for non-small cell lung cancer patients aged 75 years or older

The value of narrow-band imaging bronchoscopy in diagnosing central lung cancer

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways

Expression and clinical significance of CD31, CD34, and CD105 in pulmonary ground glass nodules with different vascular manifestations on CT

Establishment and validation of a radiological-radiomics model for predicting high-grade patterns of lung adenocarcinoma less than or equal to 3 cm

Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma

PD-1/PD-L1 immune-checkpoint blockade induces immune effector cell modulation in metastatic non-small cell lung cancer patients: A single-cell flow cytometry approach

Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity

Hospitalized cancer patients with comorbidities and low lymphocyte counts had poor clinical outcomes to immune checkpoint inhibitors

Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review

Comprehensive analyses of genomic features and mutational signatures in adenosquamous carcinoma of the lung

The combined role of PET/CT metabolic parameters and inflammatory markers in detecting extensive disease in small cell lung cancer

Drug-induced liver injury associated with dacomitinib: A case report

Neoadjuvant camrelizumab and chemotherapy in patients with resectable stage IIIA squamous non-small-cell lung cancer: Clinical experience of three cases

A detection panel of novel methylated DNA markers for malignant pleural effusion